Director & Chief Executive Officer
Director & Chief Executive Officer at BELITE BIO, INC, filing insider transactions between 2026-08-12 and 2026-09-08.
| SEC ↗ |
| 2026-09-08 | BLTE | Sale | 2,700 | $198.09 | $535K | SEC ↗ |
| 2026-09-08 | BLTE | Sale | 6,058 | $196.54 | $1.2M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 3,413 | $182.50 | $623K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 4,209 | $192.54 | $810K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 4,593 | $185.34 | $851K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 4,955 | $183.30 | $908K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 6,200 | $187.25 | $1.2M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 6,252 | $184.52 | $1.2M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 7,800 | $186.32 | $1.5M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 8,111 | $193.13 | $1.6M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 8,955 | $189.34 | $1.7M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 600 | $190.39 | $114K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 11.1K | $191.15 | $2.1M | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 2,587 | $181.24 | $469K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 2,635 | $180.29 | $475K | SEC ↗ |
| 2026-09-04 | BLTE | Sale | 3,045 | $188.26 | $573K | SEC ↗ |
| 2026-08-12 | BLTE | Sale | 142 | $180.00 | $26K | SEC ↗ |
| 2026-08-12 | BLTE | Sale | 223 | $180.57 | $40K | SEC ↗ |